TOPRA News
The future of the EMA? A question of sustainability
Following the Ernst and Young evaluation of the European Medicines Agency, a conference was held on 30 June in London to discuss its findings and recommendations for the future. The focus of the research was the Centralised Procedure and referrals. Although the EMA is delivering an increasing number of highly valued opinions of good quality involving the best experts in Europe, the number of applications has doubled since 2005 and the main committees are ‘overwhelmed with work’.
European Medicines Agency Consultation: Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development
The European Medicines Agency has published a Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development.
The scope of this paper is the co-development of a new genomic biomarker and the relevant assay(s) in the context of either a drug development or for qualification purposes.
The document is available on the following webpage:
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guidelin...
European Medicines Agency public consultation on ethical and good clinical practice (GCP) aspects of clinical trials conducted in third countries
The European Medicines Agency has published a draft 'Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted in third countries and submitted in marketing authorisation applications to the EMA'.
The document is available on the following webpage:
European Medicines Agency consultation: Guideline on Procedural advice on the Submission of Variations for Annual Update of Human Influenza Inactivated Vaccines Applications in the Centralised Procedure
The European Medicines Agency has published a Guideline on Procedural advice on the Submission of Variations for Annual Update of Human Influenza Inactivated Vaccines Applications in the Centralised Procedure (EMA/CHMP/BWP/99698/2007 Rev. 1).
The document is available on the following webpage:
European Medicines Agency consultation: Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture
The European Medicines Agency has published a Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture (EMA/CHMP/BWP/68803/2010).
The document is available on the following webpage:
http://www.ema.europa.eu/pdfs/human/bwp/6880310en.pdf
The scope of this draft guideline is to provide guidance for the isolation on cell culture of any potential influenza vaccine virus intended for cell culture or egg-based influenza vaccine manufacture.
Committee for Advanced Therapies (CAT) Update
Dear Interested Parties to the Committee for Advanced Therapies (CAT),
As some of you may be aware, at the end of each CAT plenary, the CAT Secretariat drafts a Meeting Report where it disseminates key elements of the work of the CAT. We wanted to make you aware of this document in order to aid you with the attainment of up-to-date information on the decisions made by the CAT. Please click here:
Public Consultation on the Legal Framework for Veterinary Medicinal Products
On Tuesday 13 April 2010 a public consultation was launched on the legal framework for veterinary medicinal products. The consultation can be found on to http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/new_en.htm. The closing date of the public consultation is 15 July 2010. By means of this public consultation DG SANCO intends to consult all stakeholders. An on-line tool has been designed to register your comments.
CAT monthly report for February 2010
Dear Interested Parties to the Committee for Advanced Therapies (CAT),
As some of you may be aware, at the end of each CAT plenary, the CAT Secretariat drafts a Meeting Report where it disseminates key elements of the work of the CAT. We wanted to make you aware of this document in order to aid you with the attainment of up-to-date information on the decisions made by the CAT. Please click here:
http://www.emea.europa.eu/pressoffice/cat.htm
You may consider keeping the above webpage in your favourites section for rapid access.
